Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 May;68(2):458-465.
doi: 10.1007/s12020-020-02271-y. Epub 2020 Mar 30.

Performance of a dual-component molecular assay in cytologically indeterminate thyroid nodules

Marialuisa Sponziello  1 , Chiara Brunelli  2 , Antonella Verrienti  3 , Giorgio Grani  1 , Valeria Pecce  1 , Luana Abballe  1 , Valeria Ramundo  1 , Giuseppe Damante  4 , Diego Russo  5 , Celestino Pio Lombardi  6 , Cosimo Durante  1 , Esther Diana Rossi  2 , Patrizia Straccia  2 , Guido Fadda #  2 , Sebastiano Filetti #  1
Affiliations

Performance of a dual-component molecular assay in cytologically indeterminate thyroid nodules

Marialuisa Sponziello et al. Endocrine. 2020 May.

Abstract

Purpose: Deciding whether patients with a cytologically indeterminate thyroid nodule should be referred for surgery or for active surveillance is an important challenge for clinicians. The aim of this study was to evaluate the performance of a novel dual-component molecular assay as an ancillary molecular method for resolving indeterminate thyroid nodule cytology.

Methods: We selected 156 thyroid nodules from those that had undergone fine-needle aspiration processed by liquid-based cytology and surgical resection between June 2016 and December 2017. The sample set included 63 nodules cytologically classified as indeterminate, and 93 other nodules randomly selected from those with non-diagnostic, benign, suspicious, or malignant cytology. Nucleic acids from each nodule were subjected to next-generation sequencing analysis for mutation detection in 23 genes and to digital polymerase chain reaction (PCR) evaluation for miR-146b-5p expression levels.

Results: Used alone, mutation analysis in the indeterminate subset (cancer prevalence: 22.5%) displayed high sensitivity (89%) and NPV (96%). In contrast, the miR-146b-5p assay offered high specificity (93%) and PPV (93%). Combined use of both analyses improved panel performance by eliminating false-negative results.

Conclusions: These preliminary data suggest that a dual-component molecular test can increase the diagnostic accuracy of thyroid cytology alone by reducing the number of nodules that will be classified as indeterminate and increasing those that can be reliably classified as benign. If these findings are confirmed, this test can be considered for use in clinical practice and is expected to reduce diagnostic surgery and health care costs, and to improve patient quality of life.

Keywords: Indeterminate cytology; Mutations; NGS; Thyroid nodules; dPCR; miRNA.

PubMed Disclaimer

References

    1. B.R. Haugen, E.K. Alexander, K.C. Bible, G.M. Doherty, S.J. Mandel, Y.E. Nikiforov, F. Pacini, G.W. Randolph, A.M. Sawka, M. Schlumberger, K.G. Schuff, S.I. Sherman, J.A. Sosa, D.L. Steward, R.M. Tuttle, L. Wartofsky, 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer. Thyroid 26, 1–133 (2016). https://doi.org/10.1089/thy.2015.0020 - DOI - PubMed - PMC
    1. C. Durante, G. Grani, L. Lamartina, S. Filetti, S.J. Mandel, D.S. Cooper, The diagnosis and management of thyroid nodules: a review. JAMA 319, 914–924 (2018). https://doi.org/10.1001/jama.2018.0898 - DOI - PubMed
    1. M. Bongiovanni, A. Spitale, W.C. Faquin, L. Mazzucchelli, Z.W. Baloch, The Bethesda system for reporting thyroid cytopathology: a meta-analysis. Acta Cytol. 56, 333–339 (2012). https://doi.org/10.1159/000339959 - DOI - PubMed
    1. E.S. Cibas, S.Z. Ali, The 2017 Bethesda system for reporting thyroid cytopathology. J. Am. Soc. Cytopathol. 6, 217–222 (2017). https://doi.org/10.1016/j.jasc.2017.09.002 - DOI - PubMed
    1. Z.W. Baloch, V.A. LiVolsi, S.L. Asa, J. Rosai, M.J. Merino, G. Randolph, P. Vielh, R.M. DeMay, M.K. Sidawy, W.J. Frable, Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the national cancer institute thyroid fine-needle aspiration state of the science conference. Diagn. Cytopathol. 36, 425–437 (2008). https://doi.org/10.1002/dc.20830 - DOI - PubMed

Publication types